These findings suggest that urinary nonalbumin protein (NAP) reflects tubular damage in the early-stage type 2 diabetic nephropathy. We suggest that urinary NAP could be used as a biomarker for tubular damage in clinical practice (Diabetes/Metabolism Research and Reviews)